Ambulatory Blood Pressure-Lowering Effects of Valsartan and Enalapril After a Missed Dose in Previously Untreated Patients with Hypertension : A Prospective, Randomized, Open-Label, Blinded End-Point TrialHERMIDA, Ramon C; AYALA, Diana E; KHDER, Yasser et al.Clinical therapeutics. 2008, Vol 30, Num 1, pp 108-120, issn 0149-2918, 13 p.Article

Efficacy and tolerability of combination therapy with valsartan plus hydrochlorothiazide compared with amlodipine monotherapy in hypertensive patients with other cardiovascular risk factors : The VAST studyRUILOPE, Luis M; MALACCO, Ettore; KHDER, Yasser et al.Clinical therapeutics. 2005, Vol 27, Num 5, pp 578-587, issn 0149-2918, 10 p.Article

Antihypertensive efficacy and tolerability of two fixed- dose combinations of valsartan and hydrochlorothiazide compared with valsartan monotherapy in patients with stage 2 or 3 systolic hypertension : An 8-week, randomized, double-blind, parallel-group trialLACOURCIERE, Yves; POIRIER, Luc; HEBERT, Daniel et al.Clinical therapeutics. 2005, Vol 27, Num 7, pp 1013-1021, issn 0149-2918, 9 p.Article

Effect of small angiokinase inhibitor nintedanib (BIBF 1120) on QT interval in patients with previously untreated, advanced renal cell cancer in an open-label, phase II studyEISEN, Tim; SHPARYK, Yaroslav; BONDARENKO, Igor et al.Investigational new drugs. 2013, Vol 31, Num 5, pp 1283-1293, issn 0167-6997, 11 p.Article

Dabigatran versus Warfarin in Patients with Mechanical Heart ValvesEIKELBOOM, John W; CONNOLLY, Stuart J; HARPER, Ruth et al.The New England journal of medicine. 2013, Vol 369, Num 13, pp 1206-1214, issn 0028-4793, 9 p.Article

Dabigatran vs. placebo in patients with acute coronary syndromes on dual antiplatelet therapy: a randomized, double-blind, phase II trialOLDGREN, Jonas; BUDAJ, Andrzej; GRANGER, Christopher B et al.European heart journal. 2011, Vol 32, Num 22, pp 2781-2789, issn 0195-668X, 9 p.Article